company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2012.0,Q2,2012-04-01,2012-06-30,2013-08-13 16:06:55+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2012.0,Q2,2012-04-01,2012-06-30,2013-08-13 16:06:55+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,623000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2012.0,Q2,2012-04-01,2012-06-30,2013-08-13 16:06:55+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1929000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2012.0,Q2,2012-04-01,2012-06-30,2013-08-13 16:06:55+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2552000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2012.0,Q2,2012-04-01,2012-06-30,2013-08-13 16:06:55+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-2552000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2012.0,Q2,2012-04-01,2012-06-30,2013-08-13 16:06:55+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,0.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2012.0,Q2,2012-04-01,2012-06-30,2013-08-13 16:06:55+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,3000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2012.0,Q2,2012-04-01,2012-06-30,2013-08-13 16:06:55+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,0.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2012.0,Q2,2012-04-01,2012-06-30,2013-08-13 16:06:55+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,3000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2012.0,Q2,2012-04-01,2012-06-30,2013-08-13 16:06:55+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-2549000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2012.0,Q2,2012-04-01,2012-06-30,2013-08-13 16:06:55+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-2549000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2012.0,Q2,2012-04-01,2012-06-30,2013-08-13 16:06:55+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-2549000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2012.0,Q2,2012-04-01,2012-06-30,2013-08-13 16:06:55+00:00,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,522000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2012.0,Q2,2012-04-01,2012-06-30,2013-08-13 16:06:55+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-3071000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2012.0,Q2,2012-04-01,2012-06-30,2013-08-13 16:06:55+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,300000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2012.0,Q2,2012-04-01,2012-06-30,2013-08-13 16:06:55+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-10.21
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2012.0,Q2,2012-04-01,2012-06-30,2013-08-13 16:06:55+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,300000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2012.0,Q2,2012-04-01,2012-06-30,2013-08-13 16:06:55+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-10.21
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2012.0,Q2,2012-04-01,2012-06-30,2013-08-13 16:06:55+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,300841.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2012.0,Q2,2012-04-01,2012-06-30,2013-08-13 16:06:55+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-10.21
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2012.0,Q3,2012-07-01,2012-09-30,2013-11-14 16:16:49+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1065000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2012.0,Q3,2012-07-01,2012-09-30,2013-11-14 16:16:49+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1658000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2012.0,Q3,2012-07-01,2012-09-30,2013-11-14 16:16:49+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2723000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2012.0,Q3,2012-07-01,2012-09-30,2013-11-14 16:16:49+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-2723000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2012.0,Q3,2012-07-01,2012-09-30,2013-11-14 16:16:49+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,0.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2012.0,Q3,2012-07-01,2012-09-30,2013-11-14 16:16:49+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,5000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2012.0,Q3,2012-07-01,2012-09-30,2013-11-14 16:16:49+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,5000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2012.0,Q3,2012-07-01,2012-09-30,2013-11-14 16:16:49+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-2718000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2012.0,Q3,2012-07-01,2012-09-30,2013-11-14 16:16:49+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-2718000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2012.0,Q3,2012-07-01,2012-09-30,2013-11-14 16:16:49+00:00,netincome,otheradjustmentstoconsolidatednetincome,Other Adjustments to Consolidated Net Income / (Loss),+,credit,usd,81000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2012.0,Q3,2012-07-01,2012-09-30,2013-11-14 16:16:49+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-2637000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2012.0,Q3,2012-07-01,2012-09-30,2013-11-14 16:16:49+00:00,netincometocommon,otheradjustmentstonetincometocommon,Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders),-,debit,usd,527000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2012.0,Q3,2012-07-01,2012-09-30,2013-11-14 16:16:49+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-3164000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2012.0,Q3,2012-07-01,2012-09-30,2013-11-14 16:16:49+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,300000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2012.0,Q3,2012-07-01,2012-09-30,2013-11-14 16:16:49+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-9.64
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2012.0,Q3,2012-07-01,2012-09-30,2013-11-14 16:16:49+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,300000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2012.0,Q3,2012-07-01,2012-09-30,2013-11-14 16:16:49+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-9.64
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2012.0,Q3,2012-07-01,2012-09-30,2013-11-14 16:16:49+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,328101.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2012.0,Q3,2012-07-01,2012-09-30,2013-11-14 16:16:49+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-9.64
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 17:21:50+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 17:21:50+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,0.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 17:21:50+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1226000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 17:21:50+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2114000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 17:21:50+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,0.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 17:21:50+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,0.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 17:21:50+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,3340000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 17:21:50+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-3340000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 17:21:50+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,24000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 17:21:50+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,3000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 17:21:50+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,68000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 17:21:50+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,47000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 17:21:50+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-3293000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 17:21:50+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 17:21:50+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3293000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 17:21:50+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-3293000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 17:21:50+00:00,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,773000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 17:21:50+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-4066000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 17:21:50+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,900000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 17:21:50+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-4.73
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 17:21:50+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,900000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 17:21:50+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-4.73
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 17:21:50+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,860350.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 17:21:50+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-4.73
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q2,2013-04-01,2013-06-30,2014-08-13 07:17:59+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q2,2013-04-01,2013-06-30,2014-08-13 07:17:59+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1258000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q2,2013-04-01,2013-06-30,2014-08-13 07:17:59+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2469000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q2,2013-04-01,2013-06-30,2014-08-13 07:17:59+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,0.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q2,2013-04-01,2013-06-30,2014-08-13 07:17:59+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,0.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q2,2013-04-01,2013-06-30,2014-08-13 07:17:59+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,3727000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q2,2013-04-01,2013-06-30,2014-08-13 07:17:59+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-3727000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q2,2013-04-01,2013-06-30,2014-08-13 07:17:59+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,78000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q2,2013-04-01,2013-06-30,2014-08-13 07:17:59+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,22000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q2,2013-04-01,2013-06-30,2014-08-13 07:17:59+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,343000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q2,2013-04-01,2013-06-30,2014-08-13 07:17:59+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,287000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q2,2013-04-01,2013-06-30,2014-08-13 07:17:59+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-3440000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q2,2013-04-01,2013-06-30,2014-08-13 07:17:59+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q2,2013-04-01,2013-06-30,2014-08-13 07:17:59+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3440000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q2,2013-04-01,2013-06-30,2014-08-13 07:17:59+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-3440000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q2,2013-04-01,2013-06-30,2014-08-13 07:17:59+00:00,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,808000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q2,2013-04-01,2013-06-30,2014-08-13 07:17:59+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-4248000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q2,2013-04-01,2013-06-30,2014-08-13 07:17:59+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,900000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q2,2013-04-01,2013-06-30,2014-08-13 07:17:59+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-4.62
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q2,2013-04-01,2013-06-30,2014-08-13 07:17:59+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,900000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q2,2013-04-01,2013-06-30,2014-08-13 07:17:59+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-4.62
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q2,2013-04-01,2013-06-30,2014-08-13 07:17:59+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,918397.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q2,2013-04-01,2013-06-30,2014-08-13 07:17:59+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-4.62
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 09:01:23+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 09:01:23+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1427000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 09:01:23+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3234000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 09:01:23+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,0.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 09:01:23+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,0.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 09:01:23+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,4661000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 09:01:23+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-4661000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 09:01:23+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,80000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 09:01:23+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,26000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 09:01:23+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,44000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 09:01:23+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-10000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 09:01:23+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-4671000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 09:01:23+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 09:01:23+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4671000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 09:01:23+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4671000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 09:01:23+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-4671000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 09:01:23+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,21200000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 09:01:23+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.22
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 09:01:23+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,21200000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 09:01:23+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.22
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 09:01:23+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,20806352.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 09:01:23+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.22
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q4,2013-10-01,2013-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,123000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q4,2013-10-01,2013-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,123000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q4,2013-10-01,2013-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,108000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q4,2013-10-01,2013-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,108000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,15000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4661000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3108000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,298000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,1000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,8068000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-8053000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,250000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,24000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,23000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-203000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-8256000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-12722000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q4,2013-10-01,2013-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4466000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q4,2013-10-01,2013-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,4466000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q4,2013-10-01,2013-12-31,,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,-1581000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q4,2013-10-01,2013-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,6047000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q4,2013-10-01,2013-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,11000000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q4,2013-10-01,2013-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,8.94
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q4,2013-10-01,2013-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,11000000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q4,2013-10-01,2013-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,8.94
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q4,2013-10-01,2013-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,11059382.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q4,2013-10-01,2013-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,8.94
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 16:27:17+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,176000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 16:27:17+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,176000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 16:27:17+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,0.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 16:27:17+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,176000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 16:27:17+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4612000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 16:27:17+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4229000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 16:27:17+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,539000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 16:27:17+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,18000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 16:27:17+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,9398000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 16:27:17+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-9222000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 16:27:17+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,328000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 16:27:17+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,14000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 16:27:17+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-243000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 16:27:17+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-557000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 16:27:17+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-9779000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 16:27:17+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-627000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 16:27:17+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-9152000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 16:27:17+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-9152000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 16:27:17+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-9152000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 16:27:17+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,26900000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 16:27:17+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.34
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 16:27:17+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,26900000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 16:27:17+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.34
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 16:27:17+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,26765565.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 16:27:17+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.34
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:15:17+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,300000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:15:17+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,300000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:15:17+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,0.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:15:17+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,300000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:15:17+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4404000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:15:17+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4800000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:15:17+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,582000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:15:17+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,17000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:15:17+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,9803000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:15:17+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-9503000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:15:17+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,218000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:15:17+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,13000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:15:17+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,95000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:15:17+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-110000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:15:17+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-9613000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:15:17+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-335000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:15:17+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-9278000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:15:17+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-9278000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:15:17+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-9278000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:15:17+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,29000000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:15:17+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.32
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:15:17+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,29000000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:15:17+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.32
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:15:17+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,28761326.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:15:17+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.32
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 16:19:04+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,43000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 16:19:04+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,43000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 16:19:04+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,0.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 16:19:04+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,43000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 16:19:04+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3897000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 16:19:04+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6078000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 16:19:04+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,581000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 16:19:04+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,17000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 16:19:04+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,0.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 16:19:04+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,10573000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 16:19:04+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-10530000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 16:19:04+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,222000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 16:19:04+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,31000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 16:19:04+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-10000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 16:19:04+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-201000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 16:19:04+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-10731000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 16:19:04+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-601000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 16:19:04+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10130000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 16:19:04+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10130000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 16:19:04+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-10130000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 16:19:04+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,28900000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 16:19:04+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.35
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 16:19:04+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,28900000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 16:19:04+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.35
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 16:19:04+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,29348375.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 16:19:04+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.35
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q4,2014-10-01,2014-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,248000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q4,2014-10-01,2014-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,248000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q4,2014-10-01,2014-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,333000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q4,2014-10-01,2014-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,333000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,-85000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5025000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7035000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,189000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,20000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,12269000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-12354000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,292000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,65000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,2445000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,2218000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-10136000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,120000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q4,2014-10-01,2014-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10256000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q4,2014-10-01,2014-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10256000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q4,2014-10-01,2014-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-10256000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q4,2014-10-01,2014-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,29900000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q4,2014-10-01,2014-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.29
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q4,2014-10-01,2014-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,29900000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q4,2014-10-01,2014-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.29
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q4,2014-10-01,2014-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,29767429.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q4,2014-10-01,2014-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.29
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q1,2015-01-01,2015-03-31,2015-05-08 16:27:17+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,156000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q1,2015-01-01,2015-03-31,2015-05-08 16:27:17+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,156000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q1,2015-01-01,2015-03-31,2015-05-08 16:27:17+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,110000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q1,2015-01-01,2015-03-31,2015-05-08 16:27:17+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,110000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q1,2015-01-01,2015-03-31,2015-05-08 16:27:17+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,46000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q1,2015-01-01,2015-03-31,2015-05-08 16:27:17+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4185000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q1,2015-01-01,2015-03-31,2015-05-08 16:27:17+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6221000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q1,2015-01-01,2015-03-31,2015-05-08 16:27:17+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,483000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q1,2015-01-01,2015-03-31,2015-05-08 16:27:17+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,20000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q1,2015-01-01,2015-03-31,2015-05-08 16:27:17+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,10909000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q1,2015-01-01,2015-03-31,2015-05-08 16:27:17+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-10863000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q1,2015-01-01,2015-03-31,2015-05-08 16:27:17+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,218000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q1,2015-01-01,2015-03-31,2015-05-08 16:27:17+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,71000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q1,2015-01-01,2015-03-31,2015-05-08 16:27:17+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1965000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q1,2015-01-01,2015-03-31,2015-05-08 16:27:17+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1818000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q1,2015-01-01,2015-03-31,2015-05-08 16:27:17+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-9045000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q1,2015-01-01,2015-03-31,2015-05-08 16:27:17+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-271000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q1,2015-01-01,2015-03-31,2015-05-08 16:27:17+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-8774000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q1,2015-01-01,2015-03-31,2015-05-08 16:27:17+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-8774000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q1,2015-01-01,2015-03-31,2015-05-08 16:27:17+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-8774000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q1,2015-01-01,2015-03-31,2015-05-08 16:27:17+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,33700000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q1,2015-01-01,2015-03-31,2015-05-08 16:27:17+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.26
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q1,2015-01-01,2015-03-31,2015-05-08 16:27:17+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,33700000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q1,2015-01-01,2015-03-31,2015-05-08 16:27:17+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.26
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q1,2015-01-01,2015-03-31,2015-05-08 16:27:17+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,34193994.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q1,2015-01-01,2015-03-31,2015-05-08 16:27:17+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.26
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q2,2015-04-01,2015-06-30,2015-08-07 16:15:17+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,230000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q2,2015-04-01,2015-06-30,2015-08-07 16:15:17+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,230000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q2,2015-04-01,2015-06-30,2015-08-07 16:15:17+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,109000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q2,2015-04-01,2015-06-30,2015-08-07 16:15:17+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,109000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q2,2015-04-01,2015-06-30,2015-08-07 16:15:17+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,121000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q2,2015-04-01,2015-06-30,2015-08-07 16:15:17+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4879000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q2,2015-04-01,2015-06-30,2015-08-07 16:15:17+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6081000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q2,2015-04-01,2015-06-30,2015-08-07 16:15:17+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,483000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q2,2015-04-01,2015-06-30,2015-08-07 16:15:17+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,23000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q2,2015-04-01,2015-06-30,2015-08-07 16:15:17+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,11466000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q2,2015-04-01,2015-06-30,2015-08-07 16:15:17+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-11345000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q2,2015-04-01,2015-06-30,2015-08-07 16:15:17+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,217000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q2,2015-04-01,2015-06-30,2015-08-07 16:15:17+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,43000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q2,2015-04-01,2015-06-30,2015-08-07 16:15:17+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,3176000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q2,2015-04-01,2015-06-30,2015-08-07 16:15:17+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,3002000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q2,2015-04-01,2015-06-30,2015-08-07 16:15:17+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-8343000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q2,2015-04-01,2015-06-30,2015-08-07 16:15:17+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-360000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q2,2015-04-01,2015-06-30,2015-08-07 16:15:17+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-7983000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q2,2015-04-01,2015-06-30,2015-08-07 16:15:17+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-7983000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q2,2015-04-01,2015-06-30,2015-08-07 16:15:17+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-7983000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q2,2015-04-01,2015-06-30,2015-08-07 16:15:17+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,34700000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q2,2015-04-01,2015-06-30,2015-08-07 16:15:17+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.23
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q2,2015-04-01,2015-06-30,2015-08-07 16:15:17+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,34700000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q2,2015-04-01,2015-06-30,2015-08-07 16:15:17+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.23
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q2,2015-04-01,2015-06-30,2015-08-07 16:15:17+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,34278105.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q2,2015-04-01,2015-06-30,2015-08-07 16:15:17+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.23
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q3,2015-07-01,2015-09-30,2015-11-06 16:19:04+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,229000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q3,2015-07-01,2015-09-30,2015-11-06 16:19:04+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,229000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q3,2015-07-01,2015-09-30,2015-11-06 16:19:04+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,138000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q3,2015-07-01,2015-09-30,2015-11-06 16:19:04+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,138000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q3,2015-07-01,2015-09-30,2015-11-06 16:19:04+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,91000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q3,2015-07-01,2015-09-30,2015-11-06 16:19:04+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4997000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q3,2015-07-01,2015-09-30,2015-11-06 16:19:04+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6197000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q3,2015-07-01,2015-09-30,2015-11-06 16:19:04+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,483000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q3,2015-07-01,2015-09-30,2015-11-06 16:19:04+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,23000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q3,2015-07-01,2015-09-30,2015-11-06 16:19:04+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,43398000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q3,2015-07-01,2015-09-30,2015-11-06 16:19:04+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,55098000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q3,2015-07-01,2015-09-30,2015-11-06 16:19:04+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-55007000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q3,2015-07-01,2015-09-30,2015-11-06 16:19:04+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,226000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q3,2015-07-01,2015-09-30,2015-11-06 16:19:04+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,33000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q3,2015-07-01,2015-09-30,2015-11-06 16:19:04+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,0.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q3,2015-07-01,2015-09-30,2015-11-06 16:19:04+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-193000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q3,2015-07-01,2015-09-30,2015-11-06 16:19:04+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-55200000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q3,2015-07-01,2015-09-30,2015-11-06 16:19:04+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-758000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q3,2015-07-01,2015-09-30,2015-11-06 16:19:04+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-54442000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q3,2015-07-01,2015-09-30,2015-11-06 16:19:04+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-54442000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q3,2015-07-01,2015-09-30,2015-11-06 16:19:04+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-54442000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q3,2015-07-01,2015-09-30,2015-11-06 16:19:04+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,34500000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q3,2015-07-01,2015-09-30,2015-11-06 16:19:04+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.58
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q3,2015-07-01,2015-09-30,2015-11-06 16:19:04+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,34500000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q3,2015-07-01,2015-09-30,2015-11-06 16:19:04+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.58
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q3,2015-07-01,2015-09-30,2015-11-06 16:19:04+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,34405646.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q3,2015-07-01,2015-09-30,2015-11-06 16:19:04+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.58
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q4,2015-10-01,2015-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,63000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q4,2015-10-01,2015-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,63000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q4,2015-10-01,2015-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,8000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q4,2015-10-01,2015-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,8000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,55000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5758000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6465000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,95000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,18000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,12336000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-12281000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,924000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,42000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-883000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-13164000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-309000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q4,2015-10-01,2015-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-12855000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q4,2015-10-01,2015-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-12855000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q4,2015-10-01,2015-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-12855000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q4,2015-10-01,2015-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,34300000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q4,2015-10-01,2015-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.38
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q4,2015-10-01,2015-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,34300000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q4,2015-10-01,2015-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.38
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q4,2015-10-01,2015-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,34355525.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q4,2015-10-01,2015-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.38
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:33:24+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,172000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:33:24+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,172000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:33:24+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,19000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:33:24+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,19000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:33:24+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,153000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:33:24+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6551000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:33:24+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,10749000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:33:24+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,95000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:33:24+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,18000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:33:24+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,17413000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:33:24+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-17260000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:33:24+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,849000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:33:24+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,77000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:33:24+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-35000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:33:24+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-807000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:33:24+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-18067000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:33:24+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-18067000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:33:24+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-18067000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:33:24+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-18067000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:33:24+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,34700000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:33:24+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.52
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:33:24+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,34700000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:33:24+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.52
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:33:24+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,34653479.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:33:24+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.52
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q2,2016-04-01,2016-06-30,2017-08-04 07:51:13+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,38047000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q2,2016-04-01,2016-06-30,2017-08-04 07:51:13+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,38047000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q2,2016-04-01,2016-06-30,2017-08-04 07:51:13+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1741000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q2,2016-04-01,2016-06-30,2017-08-04 07:51:13+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1741000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q2,2016-04-01,2016-06-30,2017-08-04 07:51:13+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,36306000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q2,2016-04-01,2016-06-30,2017-08-04 07:51:13+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6148000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q2,2016-04-01,2016-06-30,2017-08-04 07:51:13+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,5303000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q2,2016-04-01,2016-06-30,2017-08-04 07:51:13+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,95000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q2,2016-04-01,2016-06-30,2017-08-04 07:51:13+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,20000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q2,2016-04-01,2016-06-30,2017-08-04 07:51:13+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,2780000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q2,2016-04-01,2016-06-30,2017-08-04 07:51:13+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,14346000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q2,2016-04-01,2016-06-30,2017-08-04 07:51:13+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,21960000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q2,2016-04-01,2016-06-30,2017-08-04 07:51:13+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,846000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q2,2016-04-01,2016-06-30,2017-08-04 07:51:13+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,83000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q2,2016-04-01,2016-06-30,2017-08-04 07:51:13+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q2,2016-04-01,2016-06-30,2017-08-04 07:51:13+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-764000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q2,2016-04-01,2016-06-30,2017-08-04 07:51:13+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,21196000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q2,2016-04-01,2016-06-30,2017-08-04 07:51:13+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,21196000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q2,2016-04-01,2016-06-30,2017-08-04 07:51:13+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,21196000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q2,2016-04-01,2016-06-30,2017-08-04 07:51:13+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,20000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q2,2016-04-01,2016-06-30,2017-08-04 07:51:13+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,21176000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q2,2016-04-01,2016-06-30,2017-08-04 07:51:13+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,34762533.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q2,2016-04-01,2016-06-30,2017-08-04 07:51:13+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.61
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q2,2016-04-01,2016-06-30,2017-08-04 07:51:13+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,34938455.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q2,2016-04-01,2016-06-30,2017-08-04 07:51:13+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.61
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q2,2016-04-01,2016-06-30,2017-08-04 07:51:13+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,34700000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q2,2016-04-01,2016-06-30,2017-08-04 07:51:13+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.61
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q3,2016-07-01,2016-09-30,2017-11-03 08:01:40+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,40000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q3,2016-07-01,2016-09-30,2017-11-03 08:01:40+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,40000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q3,2016-07-01,2016-09-30,2017-11-03 08:01:40+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,286000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q3,2016-07-01,2016-09-30,2017-11-03 08:01:40+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,286000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q3,2016-07-01,2016-09-30,2017-11-03 08:01:40+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,-246000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q3,2016-07-01,2016-09-30,2017-11-03 08:01:40+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6924000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q3,2016-07-01,2016-09-30,2017-11-03 08:01:40+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,5334000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q3,2016-07-01,2016-09-30,2017-11-03 08:01:40+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,91000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q3,2016-07-01,2016-09-30,2017-11-03 08:01:40+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,19000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q3,2016-07-01,2016-09-30,2017-11-03 08:01:40+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,12368000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q3,2016-07-01,2016-09-30,2017-11-03 08:01:40+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-12614000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q3,2016-07-01,2016-09-30,2017-11-03 08:01:40+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,859000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q3,2016-07-01,2016-09-30,2017-11-03 08:01:40+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,116000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q3,2016-07-01,2016-09-30,2017-11-03 08:01:40+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-14000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q3,2016-07-01,2016-09-30,2017-11-03 08:01:40+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-757000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q3,2016-07-01,2016-09-30,2017-11-03 08:01:40+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-13371000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q3,2016-07-01,2016-09-30,2017-11-03 08:01:40+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-13371000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q3,2016-07-01,2016-09-30,2017-11-03 08:01:40+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-13371000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q3,2016-07-01,2016-09-30,2017-11-03 08:01:40+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-13371000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q3,2016-07-01,2016-09-30,2017-11-03 08:01:40+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,35200000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q3,2016-07-01,2016-09-30,2017-11-03 08:01:40+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.38
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q3,2016-07-01,2016-09-30,2017-11-03 08:01:40+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,35200000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q3,2016-07-01,2016-09-30,2017-11-03 08:01:40+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.38
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q3,2016-07-01,2016-09-30,2017-11-03 08:01:40+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,35092686.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q3,2016-07-01,2016-09-30,2017-11-03 08:01:40+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.38
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q4,2016-10-01,2016-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,292000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q4,2016-10-01,2016-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,292000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q4,2016-10-01,2016-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1093000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q4,2016-10-01,2016-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1093000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,-801000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,7719000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,9076000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,98000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,49000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,5162000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,22104000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-22905000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,842000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,109000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,305000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-428000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-23333000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q4,2016-10-01,2016-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-23333000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q4,2016-10-01,2016-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-23333000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q4,2016-10-01,2016-12-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-20000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q4,2016-10-01,2016-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-23313000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q4,2016-10-01,2016-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,35300000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q4,2016-10-01,2016-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.66
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q4,2016-10-01,2016-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,35300000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q4,2016-10-01,2016-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.66
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q4,2016-10-01,2016-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,35273228.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q4,2016-10-01,2016-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.66
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 08:02:10+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3795000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 08:02:10+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3795000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 08:02:10+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3094000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 08:02:10+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3094000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 08:02:10+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,701000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 08:02:10+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,7495000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 08:02:10+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4654000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 08:02:10+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,64000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 08:02:10+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,323000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 08:02:10+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,12536000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 08:02:10+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-11835000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 08:02:10+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,860000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 08:02:10+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,85000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 08:02:10+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-2000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 08:02:10+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-777000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 08:02:10+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-12612000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 08:02:10+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-12612000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 08:02:10+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-12612000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 08:02:10+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-12612000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 08:02:10+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,37100000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 08:02:10+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.34
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 08:02:10+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,37100000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 08:02:10+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.34
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 08:02:10+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,36711601.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 08:02:10+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.34
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q2,2017-04-01,2017-06-30,2018-08-03 16:20:54+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5158000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q2,2017-04-01,2017-06-30,2018-08-03 16:20:54+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5158000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q2,2017-04-01,2017-06-30,2018-08-03 16:20:54+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3691000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q2,2017-04-01,2017-06-30,2018-08-03 16:20:54+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3691000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q2,2017-04-01,2017-06-30,2018-08-03 16:20:54+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1467000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q2,2017-04-01,2017-06-30,2018-08-03 16:20:54+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6918000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q2,2017-04-01,2017-06-30,2018-08-03 16:20:54+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3700000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q2,2017-04-01,2017-06-30,2018-08-03 16:20:54+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,86000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q2,2017-04-01,2017-06-30,2018-08-03 16:20:54+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,353000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q2,2017-04-01,2017-06-30,2018-08-03 16:20:54+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,11057000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q2,2017-04-01,2017-06-30,2018-08-03 16:20:54+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-9590000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q2,2017-04-01,2017-06-30,2018-08-03 16:20:54+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,871000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q2,2017-04-01,2017-06-30,2018-08-03 16:20:54+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,88000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q2,2017-04-01,2017-06-30,2018-08-03 16:20:54+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-7000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q2,2017-04-01,2017-06-30,2018-08-03 16:20:54+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-790000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q2,2017-04-01,2017-06-30,2018-08-03 16:20:54+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-10380000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q2,2017-04-01,2017-06-30,2018-08-03 16:20:54+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10380000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q2,2017-04-01,2017-06-30,2018-08-03 16:20:54+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10380000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q2,2017-04-01,2017-06-30,2018-08-03 16:20:54+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-10380000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q2,2017-04-01,2017-06-30,2018-08-03 16:20:54+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,39900000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q2,2017-04-01,2017-06-30,2018-08-03 16:20:54+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.26
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q2,2017-04-01,2017-06-30,2018-08-03 16:20:54+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,39900000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q2,2017-04-01,2017-06-30,2018-08-03 16:20:54+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.26
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q2,2017-04-01,2017-06-30,2018-08-03 16:20:54+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,40206042.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q2,2017-04-01,2017-06-30,2018-08-03 16:20:54+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.26
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q3,2017-07-01,2017-09-30,2018-11-02 08:01:58+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,6163000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q3,2017-07-01,2017-09-30,2018-11-02 08:01:58+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,6163000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q3,2017-07-01,2017-09-30,2018-11-02 08:01:58+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3690000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q3,2017-07-01,2017-09-30,2018-11-02 08:01:58+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3690000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q3,2017-07-01,2017-09-30,2018-11-02 08:01:58+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2473000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q3,2017-07-01,2017-09-30,2018-11-02 08:01:58+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6910000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q3,2017-07-01,2017-09-30,2018-11-02 08:01:58+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3220000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q3,2017-07-01,2017-09-30,2018-11-02 08:01:58+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,85000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q3,2017-07-01,2017-09-30,2018-11-02 08:01:58+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,441000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q3,2017-07-01,2017-09-30,2018-11-02 08:01:58+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,10656000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q3,2017-07-01,2017-09-30,2018-11-02 08:01:58+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-8183000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q3,2017-07-01,2017-09-30,2018-11-02 08:01:58+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,870000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q3,2017-07-01,2017-09-30,2018-11-02 08:01:58+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,138000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q3,2017-07-01,2017-09-30,2018-11-02 08:01:58+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-5000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q3,2017-07-01,2017-09-30,2018-11-02 08:01:58+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-737000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q3,2017-07-01,2017-09-30,2018-11-02 08:01:58+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-8920000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q3,2017-07-01,2017-09-30,2018-11-02 08:01:58+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-8920000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q3,2017-07-01,2017-09-30,2018-11-02 08:01:58+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-8920000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q3,2017-07-01,2017-09-30,2018-11-02 08:01:58+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-8920000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q3,2017-07-01,2017-09-30,2018-11-02 08:01:58+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,42445553.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q3,2017-07-01,2017-09-30,2018-11-02 08:01:58+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.21
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q3,2017-07-01,2017-09-30,2018-11-02 08:01:58+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,42445553.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q3,2017-07-01,2017-09-30,2018-11-02 08:01:58+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.21
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q3,2017-07-01,2017-09-30,2018-11-02 08:01:58+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,42500000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q3,2017-07-01,2017-09-30,2018-11-02 08:01:58+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.21
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q4,2017-10-01,2017-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,10457000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q4,2017-10-01,2017-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,10457000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q4,2017-10-01,2017-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,5912000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q4,2017-10-01,2017-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,5912000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4545000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,7574000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3552000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,115000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,704000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,7448000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,19393000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-14848000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,880000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,138000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-8000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-750000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-15598000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q4,2017-10-01,2017-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-15598000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q4,2017-10-01,2017-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-15598000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q4,2017-10-01,2017-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-15598000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q4,2017-10-01,2017-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,40600000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q4,2017-10-01,2017-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.36
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q4,2017-10-01,2017-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,40600000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q4,2017-10-01,2017-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.36
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q4,2017-10-01,2017-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,40494301.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q4,2017-10-01,2017-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.36
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 08:02:18+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4043000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 08:02:18+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4043000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 08:02:18+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,536000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 08:02:18+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,536000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 08:02:18+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3507000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 08:02:18+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,7699000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 08:02:18+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2705000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 08:02:18+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,130000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 08:02:18+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,806000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 08:02:18+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,11340000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 08:02:18+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-7833000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 08:02:18+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,853000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 08:02:18+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,141000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 08:02:18+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-3000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 08:02:18+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-715000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 08:02:18+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-8548000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 08:02:18+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-8548000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 08:02:18+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-8548000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 08:02:18+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-8548000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 08:02:18+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,45000000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 08:02:18+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.19
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 08:02:18+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,45000000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 08:02:18+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.19
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 08:02:18+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,44788068.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 08:02:18+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.19
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q2,2018-04-01,2018-06-30,2018-08-03 16:20:54+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4908000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q2,2018-04-01,2018-06-30,2018-08-03 16:20:54+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4908000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q2,2018-04-01,2018-06-30,2018-08-03 16:20:54+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1305000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q2,2018-04-01,2018-06-30,2018-08-03 16:20:54+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1305000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q2,2018-04-01,2018-06-30,2018-08-03 16:20:54+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3603000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q2,2018-04-01,2018-06-30,2018-08-03 16:20:54+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6709000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q2,2018-04-01,2018-06-30,2018-08-03 16:20:54+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1576000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q2,2018-04-01,2018-06-30,2018-08-03 16:20:54+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,129000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q2,2018-04-01,2018-06-30,2018-08-03 16:20:54+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,915000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q2,2018-04-01,2018-06-30,2018-08-03 16:20:54+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,9329000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q2,2018-04-01,2018-06-30,2018-08-03 16:20:54+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-5726000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q2,2018-04-01,2018-06-30,2018-08-03 16:20:54+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,788000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q2,2018-04-01,2018-06-30,2018-08-03 16:20:54+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,141000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q2,2018-04-01,2018-06-30,2018-08-03 16:20:54+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-647000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q2,2018-04-01,2018-06-30,2018-08-03 16:20:54+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-6373000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q2,2018-04-01,2018-06-30,2018-08-03 16:20:54+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6373000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q2,2018-04-01,2018-06-30,2018-08-03 16:20:54+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6373000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q2,2018-04-01,2018-06-30,2018-08-03 16:20:54+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-6373000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q2,2018-04-01,2018-06-30,2018-08-03 16:20:54+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,45500000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q2,2018-04-01,2018-06-30,2018-08-03 16:20:54+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.14
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q2,2018-04-01,2018-06-30,2018-08-03 16:20:54+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,45500000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q2,2018-04-01,2018-06-30,2018-08-03 16:20:54+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.14
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q2,2018-04-01,2018-06-30,2018-08-03 16:20:54+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,46258395.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q2,2018-04-01,2018-06-30,2018-08-03 16:20:54+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.14
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q3,2018-07-01,2018-09-30,2018-11-02 08:01:58+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,21555000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q3,2018-07-01,2018-09-30,2018-11-02 08:01:58+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,21555000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q3,2018-07-01,2018-09-30,2018-11-02 08:01:58+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2172000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q3,2018-07-01,2018-09-30,2018-11-02 08:01:58+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2172000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q3,2018-07-01,2018-09-30,2018-11-02 08:01:58+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,19383000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q3,2018-07-01,2018-09-30,2018-11-02 08:01:58+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,7010000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q3,2018-07-01,2018-09-30,2018-11-02 08:01:58+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1507000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q3,2018-07-01,2018-09-30,2018-11-02 08:01:58+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,129000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q3,2018-07-01,2018-09-30,2018-11-02 08:01:58+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,1346000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q3,2018-07-01,2018-09-30,2018-11-02 08:01:58+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,9992000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q3,2018-07-01,2018-09-30,2018-11-02 08:01:58+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,9391000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q3,2018-07-01,2018-09-30,2018-11-02 08:01:58+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,716000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q3,2018-07-01,2018-09-30,2018-11-02 08:01:58+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,159000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q3,2018-07-01,2018-09-30,2018-11-02 08:01:58+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q3,2018-07-01,2018-09-30,2018-11-02 08:01:58+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-558000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q3,2018-07-01,2018-09-30,2018-11-02 08:01:58+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,8833000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q3,2018-07-01,2018-09-30,2018-11-02 08:01:58+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,8833000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q3,2018-07-01,2018-09-30,2018-11-02 08:01:58+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,8833000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q3,2018-07-01,2018-09-30,2018-11-02 08:01:58+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,8833000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q3,2018-07-01,2018-09-30,2018-11-02 08:01:58+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,47310408.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q3,2018-07-01,2018-09-30,2018-11-02 08:01:58+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.19
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q3,2018-07-01,2018-09-30,2018-11-02 08:01:58+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,47485384.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q3,2018-07-01,2018-09-30,2018-11-02 08:01:58+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.19
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q3,2018-07-01,2018-09-30,2018-11-02 08:01:58+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,46500000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q3,2018-07-01,2018-09-30,2018-11-02 08:01:58+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.19
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q4,2018-10-01,2018-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4906000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q4,2018-10-01,2018-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4906000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q4,2018-10-01,2018-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2770000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q4,2018-10-01,2018-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2770000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2136000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,7362000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1567000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,129000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,798000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,9856000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-7720000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1034000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,225000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-105000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-914000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-8634000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q4,2018-10-01,2018-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-8634000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q4,2018-10-01,2018-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-8634000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q4,2018-10-01,2018-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-8634000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q4,2018-10-01,2018-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,46000000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q4,2018-10-01,2018-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.18
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q4,2018-10-01,2018-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,46000000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q4,2018-10-01,2018-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.18
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q4,2018-10-01,2018-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,46606855.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q4,2018-10-01,2018-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.18
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2019.0,Q1,2019-01-01,2019-03-31,2019-05-09 08:02:18+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,7360000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2019.0,Q1,2019-01-01,2019-03-31,2019-05-09 08:02:18+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,7360000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2019.0,Q1,2019-01-01,2019-03-31,2019-05-09 08:02:18+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1519000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2019.0,Q1,2019-01-01,2019-03-31,2019-05-09 08:02:18+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1519000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2019.0,Q1,2019-01-01,2019-03-31,2019-05-09 08:02:18+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,5841000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2019.0,Q1,2019-01-01,2019-03-31,2019-05-09 08:02:18+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,9193000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2019.0,Q1,2019-01-01,2019-03-31,2019-05-09 08:02:18+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1775000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2019.0,Q1,2019-01-01,2019-03-31,2019-05-09 08:02:18+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,143000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2019.0,Q1,2019-01-01,2019-03-31,2019-05-09 08:02:18+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,1692000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2019.0,Q1,2019-01-01,2019-03-31,2019-05-09 08:02:18+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,12803000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2019.0,Q1,2019-01-01,2019-03-31,2019-05-09 08:02:18+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-6962000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2019.0,Q1,2019-01-01,2019-03-31,2019-05-09 08:02:18+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,174000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2019.0,Q1,2019-01-01,2019-03-31,2019-05-09 08:02:18+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2019.0,Q1,2019-01-01,2019-03-31,2019-05-09 08:02:18+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,175000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2019.0,Q1,2019-01-01,2019-03-31,2019-05-09 08:02:18+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-6787000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2019.0,Q1,2019-01-01,2019-03-31,2019-05-09 08:02:18+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6787000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2019.0,Q1,2019-01-01,2019-03-31,2019-05-09 08:02:18+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6787000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2019.0,Q1,2019-01-01,2019-03-31,2019-05-09 08:02:18+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-6787000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2019.0,Q1,2019-01-01,2019-03-31,2019-05-09 08:02:18+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,48500000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2019.0,Q1,2019-01-01,2019-03-31,2019-05-09 08:02:18+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.14
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2019.0,Q1,2019-01-01,2019-03-31,2019-05-09 08:02:18+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,48500000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2019.0,Q1,2019-01-01,2019-03-31,2019-05-09 08:02:18+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.14
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2019.0,Q1,2019-01-01,2019-03-31,2019-05-09 08:02:18+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,48277129.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2019.0,Q1,2019-01-01,2019-03-31,2019-05-09 08:02:18+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.14
